Compare PDS & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDS | INSP |
|---|---|---|
| Founded | 1951 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1998 | 2018 |
| Metric | PDS | INSP |
|---|---|---|
| Price | $77.29 | $45.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 16 |
| Target Price | ★ $122.33 | $94.00 |
| AVG Volume (30 Days) | 79.3K | ★ 823.6K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $5.66 | $8.02 |
| Revenue Next Year | $2.31 | $8.11 |
| P/E Ratio | $884.15 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $48.59 | $38.91 |
| 52 Week High | $103.80 | $147.03 |
| Indicator | PDS | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 31.51 | 56.56 |
| Support Level | $68.22 | $39.42 |
| Resistance Level | $102.00 | $58.45 |
| Average True Range (ATR) | 3.24 | 2.00 |
| MACD | -1.63 | 0.62 |
| Stochastic Oscillator | 3.08 | 95.02 |
Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.